Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats

Biological Psychiatry

Volumn 47, Issue 7, 2000, Pages 670-676

  Wadenberg, Marie Louise G ^a   Sills, Terrence L ^a   Fletcher, Paul J ^a,b   Kapur, Shitij ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Atypical antipsychotics; Catalepsy; Dopamine receptors; Prepulse inhibition of the acoustic startle reflex; Rat; Serotonin receptors

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; AMOXAPINE; APOMORPHINE; DIBENZOXAZEPINE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG ANTAGONISM; EXTRAPYRAMIDAL SYMPTOM; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ACOUSTIC STIMULATION; AMOXAPINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; CATALEPSY; DOPAMINE AGONISTS; DYSKINESIA, DRUG-INDUCED; INDOPHENOL; MALE; PROACTIVE INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; STARTLE REACTION;

EID: 0034177451     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00267-X     Document Type: Article

References (32)

1. Ahlenius S., Hillegaart V. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs A comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission . Pharmacol Biochem Behav. 24:1986;1409-1415.
2. Anton R.F. Jr, Burch E.A. Jr. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry. 147:1990;1203-1208.
3. Braff D.L., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
4. 2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology. 12:1995;139-145.
5. 2 serotonin receptors . J Med Chem. 31:1988;5-7.
6. Graham F.K. The more or less startling effects of weak prestimuli. Psychophysiology. 12:1975;238-248.
7. Greenblatt E.N., Lippa A.S., Osterberg A.C. The neuropharmacological actions of amoxapine. Arch Int Pharmacodyn Ther. 233:1978;107-135.
8. Kapur S. A new framework for investigating antipsychotic action in humans Lessons from PET imaging . Mol Psychiatry. 3:1998;135-140.
9. 2 occupancy. Biol Psychiatry. 45:1999;1217-1220.
10. Kramer M.S., Last B., Getson A., Reines S.A., Silva J.A., Wirshing W., et al. The effects of a selective D-4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. Arch Gen Psychiatry. 54:1997;567-572.
11. Li C.C. Introduction to Experimental Statistics. 1964;McGraw-Hill, New York.
12. 4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition. Psychopharmacology. 135:1998;194-200.
13. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 34:1961;102-116.
14. Meltzer HY (1989): Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99:S18-S27.
15. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats . Psychopharmacology. 124:1996;107-116.
16. 2 receptors, clozapine occupies D4. Neuropsychopharmacology. 7:1992;261-284.
17. 2 receptors, yet occupy high levels of these receptors. Mol Psychiatry. 3:1998;123-134.
18. Siegel S., Castellan N.J. Jr. Nonparametric Statistics for the Behavioral Sciences. 1988;McGraw-Hill, New York.
19. Sipes T.A., Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 33:1994;441-448.
20. 2C receptors. Behav Pharmacol. 6:1995;839-842.
21. 2A receptors in the ventral pallidum. Brain Res. 761:1997;97-104.
22. 2 receptors. J Pharmacol Exp Ther. 266:1993;1374-1384.
23. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study pathophysiology and new treatments of schizophrenia. Schizophr Bull. 24:1998;285-301.
24. Swerdlow N.R., Zisook D., Taaid N. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats Similarities to clozapine . Psychopharmacology. 114:1994;675-678.
25. Tang A.H., Franklin S.R., Himes C.S., Smith M.W., Tenbrink R.E. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J Pharmacol Exp Ther. 281:1997;440-447.
26. Varty G.B., Higgins G.A. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology. 122:1995;15-26.
27. Wadenberg M.-L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev. 20:1996;325-339.
28. 2A receptor antagonist MDL 100,907. Biol Psychiatry. 44:1998;508-515.
29. 2 receptor blocking agent ritanserin, in the rat. Eur Neuropsychopharmacol. 6:1996;305-310.
30. Wander T.J., Nelson A., Okazaki H., Richelson E. Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro. Eur J Pharmacol. 132:1986;115-121.
31. Wilcox R.E., Humphrey D.W., Riffee W.H., Smith R.V. Stability of apomorphine in solutions containing ascorbic acid and bisulfite and effects of antioxidants on apomorphine-induced cage climbing and hypothermia in mice. J Pharmacol Sci. 69:1980;974-976.
32. Wu M.F., Mallick B.N., Siegel J.M. Lateral geniculate spikes, muscle atonis and startle response elicited by auditory stimuli as a function of stimulus parameters and arousal state. Brain Res. 499:1989;7-17.